All Updates

All Updates

icon
Filter
M&A
Big Health acquires Limbix for undisclosed amount
Mental Health Tech
Jul 14, 2023
This week:
Product updates
Pimax announces compact Dream Air VR headset for USD 1,900
Extended Reality
Dec 23, 2024
Funding
HuLoop raises Series A funding from Mighty Capital
Workflow Automation Platforms
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
Financial Wellness Tools
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
FinTech Infrastructure
Dec 23, 2024
Funding
Meight raises EUR 3.4 million in funding led by Cusp Capital
Smart Mobility Information
Dec 23, 2024
Regulation/policy
Desktop Metal sues Nano Dimension over merger compliance
Additive Manufacturing
Dec 23, 2024
Management news
Nexa3D scales back operations amid financial crisis
Additive Manufacturing
Dec 23, 2024
Funding
Fraction AI raises USD 6 million in pre-seed funding to scale hybrid data labeling
Machine Learning Infrastructure
Dec 23, 2024
Last week:
Partnerships
Rocket Lab launches sixth Synspective radar satellite as part of ongoing partnership
Space Travel and Exploration Tech
Dec 21, 2024
Partnerships
EHang partners with Changan Automobile to develop eVTOL aircraft for personal transportation
Passenger eVTOL Aircraft
Dec 21, 2024
Mental Health Tech

Mental Health Tech

Jul 14, 2023

Big Health acquires Limbix for undisclosed amount

M&A

  • Digital therapeutics provider Big Health has acquired a digital therapeutics provider for adolescents, Limbix, for an undisclosed amount. This acquisition marks the entry of Big Health into the adolescent mental health market.

  • Through the acquisition, Big Health will add Limbix’s digital therapeutics (DTx) to its portfolio. This addition will include both of Limbix’s DTx solutions, Daylight therapeutic (for anxiety), Sleepio (for insomnia), and SparkRx (for adolescent depression). Additionally, a DTx solution for adolescent anxiety, which is currently under development by Limbix, will also be absorbed into Big Health’s portfolio.    

  • Additionally, through the acquisition, SparkRx will be made available to Big Health’s various customers (employers, public sector, health systems, and health plans), as well as through the company's partnership agreements with pharmacy benefit managers across the US. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.